Acitretin Market Outlook - 2027
Acitretin is referred as a retinoid that is a form of vitamin A. It is a second generation antipsoriatic drug. It is a prescription drug mainly applied to treat the psoriasis disease. It is long term use drug. It is found commonly in capsule type. It is not a principal cure for the psoriasis disease and it may result in the relapse after the termination of medication. It may have various side effects like severe birth defects in the pregnant females and severe liver problems. This medication must be avoided in the patients having severe kidney disease, high level of triglycerides in the blood, pregnant females, and others. Conversely, overdose of this medication may result in headache and dizziness. Usual adult dose of in case of psoriasis is 25-50 mg once a day. It is administered as a single dose. It acts by binding to the receptors in the body. It slows down the proliferation of the skin cells. The affected skin either gets removed or gets cleared. It may be used in the psoriatic arthritis, pityriasis rubra pilaris, psoriasis, palmoplantar pustulosis, hand dermatitis, darier disease, lichen planus, lichen sclerosis, lupus erythematous, cutaneous t-cell lymphoma, extensive granuloma annulare, severe ichthyosis, actinic keratoses, skin cancers and extensive warts. The various interactions of this disease are vitamin, tetracycline, methotrexate, and phenytoin.
COVID-19 Scenario analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine, have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.
Top impacting factors: Market Scenario Analysis, Trends, Drivers, Impact Analysis
The increase in the number of patients of the psoriasis and also the presence of the pipeline drugs is supposed to fuel the growth of the acitretin market. Furthermore, increase in demand for organ transplantation can also fuel the growth of the market. The diagnosis and the treatment development can improve the growth factor of the market. In addition, R&D activities in this field and rise in expenditure factor for the health care sector can hike the growth of the market and can take it to another level.
However, adverse effects caused by this drug, availability of another drug and problems faced in the supply chain are expected to hamper the growth of global acitretin market.
New drug launches to flourish the market:
In April 2018, Pediatric pharmacy advocacy group published about the unique preparation and delivery method for acitretin for neonatal harlequin ichthyosis. No authors were found to be in conflict about the manuscripts, products, grants and medication.
In May 2020, Allergen plc, a manufacturer of the acitretin drug was acquired and merged in to AbbVie Inc. This helped to develop the service of production and distribution of the drug acitretin.
Surge in the usage of the acitretin:
Increase in the prevalence of the psoriasis and the health care expenditure can increase the usage of the acitretin. Furthermore, upsurge in the awareness of the treatment of the disease can help to surge the usage of the acitretin in the hospital sector.
Key benefits of the report:
- This study presents the analytical depiction of the global acitretin market industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global acitretin market share.
- The current market is quantitatively analyzed to highlight the acitretin market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global acitretin market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the acitretin market research report:
- What are the leading market players active in the acitretin market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Acitretin Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By Dose strength |
|
 By Application |
|
 By DISTRIBUTION CHANNEL |
|
 By Region |
|
 Key Market Players | Merck KGaA, Chongqing Huapont Pharmaceutical Co., Ltd., AvKARE, LLC., Biophore India Pharmaceuticals Pvt Ltd, Sun Pharma Industries Limited., Teva Pharmaceuticals USA, Inc., Sionc Pharmaceuticals Pvt Ltd., Glopec International Inc., Stiefel Laboratories Inc., SGPharma Pvt Ltd., Prasco Laboratories, Hangzhou Jinlan Pharmaceutical Technology Development Co., Ltd, others. |
Loading Table Of Content...
